Johnson & Johnson Stock Is Rising Because Its Earnings Beat Trumps a Sales Miss

2 years ago 212

This transcript is for your personal, non-commercial usage only. To bid presentation-ready copies for organisation to your colleagues, clients oregon customers sojourn http://www.djreprints.com.

https://www.barrons.com/articles/johnson-johnson-jnj-stock-earnings-51634640331

Updated Oct. 19, 2021 7:21 americium ET / Original Oct. 19, 2021 6:46 americium ET

Order Reprints
Print Article

Johnson & Johnson banal is gaining aft the pharmaceutical elephantine reported net that topped expert estimates.

Johnson & Johnson (JNJ) reported an adjusted nett of $2.60 a share, beating forecasts for $2.35 a share, connected income of $23.33 billion, missing expectations for $$23.72 billion.

“Our third-quarter results show coagulated performance...

Read Entire Article